Tag archive for ‘Teva Pharmaceutical Industries’
Jewish Business News On Monday, November 6th, 2017

Len Blavatnik Examines $3 Billion Investment in Teva

Facebook0 Twitter Google Plus0 Pinterest0 Email     Billionaire Len Blavatnik is considering investing $ 3 billion in Teva Pharmaceutical Industries, The Marker has learned. Blavatnik may acquire a More...

Albert Hecht On Monday, September 11th, 2017

New Teva CEO Kare Schultz Grants $20 Million in Cash, $13.5 Million in Securities

Facebook0 Twitter Google Plus0 Pinterest0 Email New Teva CEO Kare Schultz will earn an annual salary of $2 million and a performance-dependent bonus of 140% of the base salary – and up to a maximum of More...

Omri Cohen On Thursday, August 3rd, 2017

Drama in Teva: Cutting 7,000 Jobs in 45 Countries ; Share Price Plunges

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva Pharmaceutical Industries announced today that it is cutting 7,000 jobs in 45 countries and will close 15 factories by the end of 2018, following the publication More...

Shai Genish On Thursday, December 22nd, 2016

Israeli Drugmaker Teva Pays $519 Million Fine in US for Foreign Bribes

Facebook0 Twitter Google Plus0 Pinterest0 Email US Justice Department announced Thursday that Israeli Teva Pharmaceutical Industries will pay $519 million fine to settle charges concerning violations More...

Jewish Business News On Monday, September 19th, 2016

Teva’s Trial Results Finds Drug Could Slow Huntington’s Disease

Facebook0 Twitter Google Plus0 Pinterest0 Email Teva Pharmaceutical Industries Ltd. today announced top-line results from an exploratory dose-ranging Phase 2 clinical trial, which could be a major breakthrough More...

Teva Completes Acquisition of Allergan’s Generics Business – Actavis Generics

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva Pharmaceutical Industries Ltd. and Allergan plc today announced that Teva has completed its acquisition of Allergan’s generics business – Actavis More...

Teva Buys Allergan Distributor Anda for $500 Million

Facebook0 Twitter Google Plus0 Pinterest0 Email   One day after Teva Pharmaceutical Industries closed its deal to buy Allergan’s generics business for $33.43 billion in cash and $5.3 billion in shares, More...

Teva Sells $15 Billion of Bonds

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva Pharmaceutical Industries Ltd. announced today that it sold $15 billion bond offering, Monday to help fund its acquisition of Allergan PLC’s generics More...

Ilan Shavit On Thursday, February 18th, 2016

Teva Offering Concessions for Allergan Takeover – Bloomberg

Facebook0 Twitter Google Plus0 Pinterest0 Email   Teva Pharmaceutical Industries Ltd. will try to win fast European Union approval for its takeover of Allergan’s generics unit by making concessions More...

AAI Letter to the FTC: Generic Pharmaceutical Merger TEVA and ALLERGAN Will Eliminate Important Competition

Facebook0 Twitter Google Plus0 Pinterest0 Email In a letter to the Federal Trade Commission (FTC), The American Antitrust Institute (AAI), a non-profit organization, outlined the competitive concerns More...

Email:

Delivered by FeedBurner